Paper35192
Single daily dose treatment of anxiety with clobazam or dipotassium clorazepate.
Wallis TD and 4 others. Br J Clin Pharmacol, 1979. Cited by 5 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Single daily dose treatment of anxiety with clobazam or dipotassium clorazepate. Papers, record 35192. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35192
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Clinical Trial, Comparative Study, Controlled Clinical Trial, Journal Article, Randomized Controlled Trial
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-Anxiety Agents | Major topic |
| Anxiety | Major topic |
| Clorazepate Dipotassium | Major topic |
| Adolescent | |
| Adult | |
| Age Factors | |
| Clinical Trials as Topic | |
| Double-Blind Method | |
| Drug Administration Schedule | |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| Sex Factors |
Source PubMed
References6
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 241,987 | A single-dose anti-anxiety drug. A report from the General Practitioner Research Group. | Practitioner | 1975 | https://conductscience.org/library/papers/241987 | PubMed |
| 2 | 27,539 | Clobazam versus diazepam--a double-blind study in anxiety neurosis. | J Clin Pharmacol | 1978 | https://conductscience.org/library/papers/27539 | PubMed |
| 3 | 35,189 | Evaluation of the effects of clobazam, A 1,5 benzodiazepine, on mood and psychomotor performance in clinically anxious patients in general practice. | Br J Clin Pharmacol | 1979 | https://conductscience.org/library/papers/35189 | PubMed |
| 4 | 35,197 | Review of clinical studies on clobazam. | Br J Clin Pharmacol | 1979 | https://conductscience.org/library/papers/35197 | PubMed |
| 5 | 35,215 | Anxiety reduction and sedation: psychophysiological theory. | Br J Clin Pharmacol | 1979 | https://conductscience.org/library/papers/35215 | PubMed |
| 6 | 4,590,788 | Once-a-day potassium clorazepate in anxiety. | Br J Clin Pract | 1973 | https://conductscience.org/library/papers/4590788 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 6,125,394 | Clobazam: single or divided doses? | Eur J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/6125394 | PubMed |
| 6,107,238 | Clobazam: a review of its pharmacological properties and therapeutic use in anxiety. | Drugs | 1980 | https://conductscience.org/library/papers/6107238 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35192
GET https://conductscience.org/api/papers/v1/35192/authors